3 completed, 1 terminated. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 3, Terminated 1 |
Follow Agoraphobia: new trials by email Literature Review of Agoraphobia trials Research Report on Agoraphobia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity Methylphenidate Hydrochloride Controlled-Release Capsules, Placebo Capsule - Attention Deficit Hyperactivity Disorder, Generalized Anxiety Disorder | Phase 4 | Completed | McMaster University | 60 | 2019-04-20 | 2023-10-26 |
| Treatments for Anxiety: Meditation and Escitalopram Mindfulness-Based Stress Reduction, Escitalopram - Anxiety Disorders, Generalized Anxiety Disorder | Phase 4 | Completed | Georgetown University | 276 | 2018-06-18 | 2022-01-11 |
| Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders Sertraline, Placebo - Phobia, Social, Panic Disorder | Phase 4 | Terminated | Hamilton Health Sciences Corporation | 170 | 2002-07-01 | 2018-03-22 |
| Long Term Treatment of Panic Disorder With Clonazepam or Paroxetine Clonazepam, Paroxetine - Panic Disorder, Agoraphobia | Phase 4 | Completed | Universidade Federal do Rio de Janeiro | 120 | 2000-01-01 | 2016-08-02 |
Panic Disorder (4) · Anxiety Disorders (3) · Phobia, Social (3) · Generalized Anxiety Disorder (2) · Attention Deficit Disorder with Hyperactivity (1) · Depressive Disorder, Major (1) · Dysthymic Disorder (1) · Obsessive-Compulsive Disorder (1)
Mental Disorders (4) · Phobic Disorders (4) · Anxiety Disorders (1) · Attention Deficit and Disruptive Behavior Disorders (1) · Depressive Disorder (1) · Mood Disorders (1) · Neurodevelopmental Disorders (1)
Clonazepam (1) · Escitalopram (1) · Mindfulness-Based Stress Reduction (1) · Paroxetine (1) · Sertraline (1)
Georgetown University (1) · Hamilton Health Sciences Corporation (1) · McMaster University (1) · Universidade Federal do Rio de Janeiro (1)
Canada (2) · Brazil (1) · United States (1)
Michael Van Ameringen, MD, FRCPC (2) · Rafael C Freire, MD, PhD (1)
PMID 21344132, PMID 21364347, PMID 22198456, PMID 36350591, PMID 39134156, PMID 39382900, PMID 40324655